Science Applications International (SAIC)
(Delayed Data from NSDQ)
$134.74 USD
+0.23 (0.17%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $134.72 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Science Applications International Corporation falls in the month of January.
All items in Millions except Per Share data.
1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 94 | 109 | 106 | 171 | 188 |
Receivables | 914 | 936 | 1,015 | 962 | 1,099 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 71 | 64 | 78 | 84 |
Other Current Assets | 120 | 81 | 78 | 78 | 59 |
Total Current Assets | 1,131 | 1,197 | 1,263 | 1,289 | 1,430 |
Net Property & Equipment | 91 | 92 | 100 | 108 | 91 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,745 | 3,920 | 4,045 | 3,925 | 2,850 |
Deposits & Other Assets | 195 | 176 | 129 | 165 | 150 |
Total Assets | 5,314 | 5,543 | 5,746 | 5,723 | 4,711 |
Liabilities & Shareholders Equity | 1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 567 | 624 | 612 | 517 | 527 |
Current Portion Long-Term Debt | 77 | 31 | 148 | 68 | 70 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 514 | 471 | 592 | 690 | 531 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,158 | 1,126 | 1,352 | 1,275 | 1,128 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 28 | 0 | 43 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 2,022 | 2,343 | 2,370 | 2,447 | 1,851 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 174 | 218 | 160 | 244 | 133 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,529 | 3,839 | 4,117 | 4,171 | 3,284 |
Shareholders Equity | 1/31/2024 | 1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 337 | 637 | 838 | 1,004 | 983 |
Retained Earnings | 1,432 | 1,035 | 818 | 627 | 506 |
Other Equity | 16 | 32 | -27 | -79 | -62 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,785 | 1,704 | 1,629 | 1,552 | 1,427 |
Total Liabilities & Shareholder's Equity | 5,314 | 5,543 | 5,746 | 5,723 | 4,711 |
Total Common Equity | 1,785 | 1,704 | 1,629 | 1,552 | 1,427 |
Shares Outstanding | 52.00 | 54.60 | 56.90 | 58.20 | 57.70 |
Book Value Per Share | 34.33 | 31.21 | 28.63 | 26.67 | 24.73 |
Fiscal Year End for Science Applications International Corporation falls in the month of January.
All items in Millions except Per Share data.
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 48 | 49 | 94 | 311 | 352 |
Receivables | 946 | 934 | 914 | 1,010 | 958 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 3 | 67 | 74 |
Other Current Assets | 109 | 108 | 120 | 0 | 0 |
Total Current Assets | 1,103 | 1,091 | 1,131 | 1,388 | 1,384 |
Net Property & Equipment | 95 | 93 | 91 | 89 | 90 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3,687 | 3,716 | 3,745 | 3,774 | 3,802 |
Deposits & Other Assets | 197 | 202 | 195 | 271 | 256 |
Total Assets | 5,250 | 5,250 | 5,314 | 5,658 | 5,672 |
Liabilities & Shareholders Equity | 7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 639 | 648 | 567 | 840 | 820 |
Current Portion Long-Term Debt | 197 | 90 | 77 | 69 | 62 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 456 | 416 | 514 | 317 | 330 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 1,292 | 1,154 | 1,158 | 1,226 | 1,212 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 19 | 29 | 28 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,970 | 1,993 | 2,022 | 2,194 | 2,215 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 186 | 174 | 278 | 264 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3,625 | 3,491 | 3,529 | 3,830 | 3,829 |
Shareholders Equity | 7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | 7/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 63 | 251 | 337 | 395 | 480 |
Retained Earnings | 1,551 | 1,489 | 1,432 | 1,413 | 1,340 |
Other Equity | 11 | 19 | 16 | 20 | 23 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,625 | 1,759 | 1,785 | 1,828 | 1,843 |
Total Liabilities & Shareholder's Equity | 5,250 | 5,250 | 5,314 | 5,658 | 5,672 |
Total Common Equity | 1,625 | 1,759 | 1,785 | 1,828 | 1,843 |
Shares Outstanding | 49.50 | 51.20 | 52.00 | 52.00 | 52.90 |
Book Value Per Share | 32.83 | 34.36 | 34.33 | 35.15 | 34.84 |